Latest News

September 1, 2021

NIH Awards $1.4 Million for Sleep and Dementia Research

Principal investigators Tiffany Braley MD, MS and Galit Levi Dunietz PhD, MPH were recently awarded $1.4M in new R01 funding by the National Institute on Aging to study unexplored pathways between obstructive sleep apnea (OSA), OSA treatment, and dementia risk in older women and men. To study these pathways, Braley and Dunietz will utilize

September 1, 2021

NIH Awards $3.3 Million for Research on Cannabinoids in People with Multiple Sclerosis

Principal investigators Tiffany Braley MD, MS (Neurology) and Anna Kratz PhD (Physical Medicine and Rehabilitation) were recently awarded $3.3M in new R01 funding from the National Center for Complimentary and Integrative Health to conduct research on the effects of cannabinoids on sleep and pain in people with MS. This mechanistic trial will

July 30, 2021

New Research Highlights Important Pathway for Drug Treatment in Alzheimer’s Disease, Parkinson’s Disease, and Frontotemporal Dementia

Ann Arbor, MI – The work of affiliates of the Michigan Alzheimer’s Disease Research Center captured the attention of the Journal of Biological Chemistry last week for their new findings which could change the trajectory of treatment for key neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and

Pages